The Fat Jab: What Movement and Therapy Professionals Need to Know About GLP-1 Weight Loss
When the weight comes off, what else might be lost?
GLP-1 drugs such as Wegovy, Mounjaro and Ozempic are helping millions of people lose substantial amounts of weight.
But rapid weight loss does not remove fat alone. Muscle and bone may also be affected, particularly when people are eating less, moving less and doing no resistance training.
This creates an important new role for personal trainers, Pilates teachers, movement professionals and hands-on therapists.
Many GLP-1 users have little experience of exercise, low confidence, existing pain or reduced mobility. They may not need another punishing weight-loss programme. They may need help becoming stronger while their body is changing.
In this webinar, we will explore how the drugs work, what rapid weight loss may mean for muscle, bone, energy and movement, and how practitioners can support these clients safely and within their professional scope.
We'll Explore:
What GLP-1, GIP and related weight-loss medications actually do
Why these drugs can produce such substantial reductions in body weight
The difference between weight loss, fat loss and lean-mass loss
Why previously inactive people may be particularly vulnerable to losing strength
The possible effects of substantial weight loss on bone density
Why resistance exercise and weight-bearing activity are vital
GLP-1 use and injury risk
Introducing exercise without frightening or overwhelming new clients
How Pilates, gym work, home-based resistance training and everyday loading can contribute
What hands-on therapists may notice when clients lose weight quickly
How practitioners can create ethical, evidence-informed services for people using weight-loss medication
Why working the hips doesn't always improve stability
For permanent access to this and previous webinars
Join the Archive Membership
£12.50
per month
ABOUT THIS WEBINAR
Weight Loss Jabs - What Manual and Movement Therapists Need to Know
In this webinar we'll explore:
The common and often misleading belief that obesity is simply a consequence of eating too much
The difference between losing weight and improving long-term health
Why existing patterns and habits will inform the success of weight loss more than medications
The difference between obesity and the associated behaviours associated with obesity
How to help the transition when weight loss medications stop
How the brain, gut, hormones and environment work together to regulate appetite and body weight
How nutrition is even more important when calorie intake is dramatically reduced
How muscle mass is affected by rapid weight loss
How emotional, social and environmental factors continue to influence eating behaviours despite appetite suppression
Why does this subject matter for your practice?
People using weight-loss medication are often told that they should exercise, preserve muscle and improve their diet. That advice is easy to give and much harder to put into practice.
Many may have never entered a weights area, have no idea how to begin resistance training, feel self-conscious about exercising, experience joint pain or have previously been sold exercise primarily as punishment for being overweight.
A practitioner who understands both the benefits and the limitations of GLP-1 treatment can offer something different: a safe, non-judgemental route into strength, movement and physical confidence.
This is not about exploiting people’s anxiety or promising to prevent every side effect. It is about recognising a genuine and rapidly growing need.
The injection may help someone lose weight, but it cannot teach them how to lift, balance, move confidently, maintain physical capacity or build a body that remains useful.
This is where movement professionals can play an important role, especially if they understand the processes involved .
Who is this webinar for?
Personal trainers and strength coaches
Pilates and yoga teachers
Physiotherapists and rehabilitation professionals
Massage therapists
Bowen practitioners
Osteopaths and chiropractors
Manual therapists
Health and movement educators
Anyone working with clients currently using GLP-1 medication
Frequently Asked Questions FAQs
What are GLP-1 weight loss injections?
GLP-1 weight loss injections are medicines that affect appetite, satiety and metabolic signalling. Examples include Wegovy and Mounjaro.
How do Wegovy and Mounjaro work?
They act on hormonal signalling systems involved in hunger, fullness and blood glucose regulation.
Is this webinar medical advice?
No. This is an educational webinar for health and movement professionals. It does not replace advice from a qualified prescriber.
Is this webinar anti-GLP-1 medication?
Not at all! These drugs can provide substantial benefits for people living with obesity and related health problems. The session takes a balanced look at both their benefits and the practical challenges surrounding rapid weight loss.
Are GLP-1 drugs proven to cause muscle wasting?
Weight loss generally includes some loss of lean mass, whether it results from medication, dieting or bariatric surgery. GLP-1 users may lose lean tissue because they are consuming less energy and losing considerable weight, but the amount varies. Lean mass measured in research is also not synonymous with skeletal muscle.
The practical concern is whether a person retains strength, function and sufficient muscle while losing weight.
Is this webinar suitable for people currently taking a GLP-1 drug?
Yes, although it is designed primarily for people working in fitness, movement, rehabilitation and manual therapy. It is educational and does not replace individual medical advice.
What is the relevance for massage, Bowen or other manual therapy practitioners?
Hands-on practitioners frequently see clients who do not yet identify as exercisers. They may therefore be ideally placed to notice rapid physical change, declining strength, dizziness, fatigue or reduced activity and to encourage appropriate medical review or gradual movement support.
The treatment itself should not be presented as preventing muscle or bone loss. Its value may lie in conversation, confidence, symptom support within scope and creating a bridge into movement.
Sources informing this webinar
This webinar draws on publicly available guidance and research from organisations including the NHS, NICE, UK public health data and peer-reviewed medical literature on GLP-1 receptor agonists, obesity, appetite and metabolic health.
READ SOME REVIEWS
Don't just take our word for it...
"To 'see' the soft tissue we as therapists think we influence is a privilege. Julian Baker makes all the right connections between the 'tissue' and considerations for therapeutic intervention. Functional Anatomy is a must for all 'hands on' therapists. It is also a must for the 'hands off' body of therapists! Seeing is believing.."
"Captivating, often bizarre and incredible insights into the human body like you have never seen before. Always life changing sessions, questioning the “norm” as we are taught it and bringing new dimensions to your practise.
If you attend one of Julian's classes your working brain will be changed forever - for the better and you will only want to see more!! His humour is also legendary!!"
"I have just participated in the scar tissue dissection course. This is an incredible lesson in anatomy. Julian takes you on a journey thru a human body like you've never been before. It is amazing to see how a human body is really built, how strong, how resilient. Eye-opening and educating. Thank you.
I will be back for more."
ARE YOU READY TO BUY THIS WEBINAR?
We're excited to have you on board!
Site: www.touchmoveheal.com
Email: [email protected]
Touch Move Heal All rights reserved